Results 211 to 220 of about 1,541,253 (387)

Effects of Serotonin Antagonists in Normal Subjects and Patients with Carcinoid Tumors

open access: bronze, 1957
Roland E. Schneckloth   +3 more
openalex   +1 more source

Unveiling unique protein and phosphorylation signatures in lung adenocarcinomas with and without ALK, EGFR, and KRAS genetic alterations

open access: yesMolecular Oncology, EarlyView.
Proteomic and phosphoproteomic analyses were performed on lung adenocarcinoma (LUAD) tumors with EGFR, KRAS, or EML4–ALK alterations and wild‐type cases. Distinct protein expression and phosphorylation patterns were identified, especially in EGFR‐mutated tumors. Key altered pathways included vesicle transport and RNA splicing.
Fanni Bugyi   +12 more
wiley   +1 more source

Origami-inspired reprogrammable microactuator system. [PDF]

open access: yesMicrosyst Nanoeng
Gottwald V   +8 more
europepmc   +1 more source

ANTAGONISTS OF NUCLEIC ACID DERIVATIVES

open access: hybrid, 1951
Gertrude B. Elion, George H. Hitchings
openalex   +1 more source

The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist.

open access: yesProceedings of the National Academy of Sciences of the United States of America, 1986
E. Wong   +5 more
semanticscholar   +1 more source

Targeting of PTP4A3 overexpression sensitises HGSOC cells towards chemotherapeutic drugs

open access: yesMolecular Oncology, EarlyView.
In HGSOC with normal KRAS expression, high PTP4A3 expression regulates autophagy activation. Conversely, in HGSOC with high KRAS expression, KRAS dictates autophagy control, and PTP4A3 is not required. When high PTP4A3 expression is inhibited, HGSOC cells are preferentially sensitised towards DNA‐damaging agents.
Ana López‐Garza   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy